RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS

IST:RTALB (Turkey)  
₺ 11.27 (-0.62%) Jun 3
4.03
P/B:
1.24
Market Cap:
₺ 1.13B ($ 34.79M)
Enterprise V:
₺ 1.04B ($ 32.22M)
Volume:
1.25M
Avg Vol (2M):
3.14M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS ( IST:RTALB ) from 2014 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS stock (IST:RTALB) PE ratio as of Jun 04 2024 is 4.03. More Details

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS (IST:RTALB) PE Ratio (TTM) Chart

To

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS (IST:RTALB) PE Ratio (TTM) Historical Data

Total 1271
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-04 4.0 2024-03-25 4.4
2024-06-03 4.0 2024-03-22 4.5
2024-05-31 4.0 2024-03-21 4.5
2024-05-30 4.1 2024-03-20 4.4
2024-05-29 4.1 2024-03-19 4.4
2024-05-28 4.2 2024-03-18 4.3
2024-05-27 4.2 2024-03-15 4.6
2024-05-24 4.3 2024-03-14 4.6
2024-05-23 4.5 2024-03-13 4.6
2024-05-22 4.5 2024-03-12 4.7
2024-05-21 4.4 2024-03-11 4.8
2024-05-20 4.5 2024-03-08 4.9
2024-05-17 4.4 2024-03-07 4.9
2024-05-16 4.4 2024-03-06 4.7
2024-05-15 4.3 2024-03-05 5.0
2024-05-14 4.3 2024-03-04 5.0
2024-05-13 4.3 2024-03-01 5.2
2024-05-10 4.4 2024-02-29 5.2
2024-05-09 4.7 2024-02-28 5.1
2024-05-08 4.7 2024-02-27 5.2
2024-05-07 4.5 2024-02-26 5.5
2024-05-06 4.7 2024-02-23 5.6
2024-05-03 4.7 2024-02-22 5.7
2024-05-02 4.5 2024-02-21 5.6
2024-04-30 4.4 2024-02-20 5.8
2024-04-29 4.5 2024-02-19 5.8
2024-04-26 4.6 2024-02-16 5.8
2024-04-25 4.6 2024-02-15 5.7
2024-04-24 4.6 2024-02-14 5.7
2024-04-22 4.6 2024-02-13 5.3
2024-04-19 4.6 2024-02-12 5.6
2024-04-18 4.6 2024-02-09 5.6
2024-04-17 4.7 2024-02-08 5.6
2024-04-16 4.2 2024-02-07 5.5
2024-04-15 4.4 2024-02-06 5.6
2024-04-08 4.3 2024-02-05 5.4
2024-04-05 4.1 2024-02-02 5.4
2024-04-04 4.0 2024-02-01 5.3
2024-04-03 4.0 2024-01-31 5.3
2024-04-02 4.1 2024-01-30 5.2
2024-04-01 4.2 2024-01-29 5.3
2024-03-29 4.4 2024-01-26 5.4
2024-03-28 4.4 2024-01-25 5.4
2024-03-27 4.4 2024-01-24 5.4
2024-03-26 4.4 2024-01-23 5.4

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS (IST:RTALB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS is engaged in research, development, and production of Vitro diagnostics. The company offers Real-Time PCR Kits, Nucleic Acid Isolation Kits, and DNA qPCR Probe Master Mix Kit.